COVID-19 has decreased the number of available transportation routes and presented distribution challenges. This has added a level of complexity to supplying clinical trials domestically and internationally. In this chat, PCI’s Distribution Manager Thomas Johnson will share his observations on how COVID-19 has impacted clinical supply chains. We will also have a special guest David Spillett, Global Accounts Director from World Courier to share his observations.
This chat will specifically focus on how COVID-19 has impacted:
- Domestic and international distribution trends
- Availability of active and passive packing systems
- Availability of transportation lanes
Just-In-Time clinical studies